Skip to main content
ELVN logo

ELVN · Enliven Therapeutics, Inc. · Analyst Estimates

Track ELVN — free
$54.32 -1.91 (-3.40%) At close · Sep 11
Market Cap
$3.98B
Shares
73.27M

Analyst Estimates

Compare analyst forecasts for Enliven Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1672619 CUSIP 29337E102 13F (30d) 135 filings 135 filers Visit website Investor relations